Correlation Between SUMITOMO P and Takeda Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SUMITOMO P and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SUMITOMO P and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SUMITOMO P SP and Takeda Pharmaceutical, you can compare the effects of market volatilities on SUMITOMO P and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SUMITOMO P with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of SUMITOMO P and Takeda Pharmaceutical.

Diversification Opportunities for SUMITOMO P and Takeda Pharmaceutical

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between SUMITOMO and Takeda is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding SUMITOMO P SP and Takeda Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and SUMITOMO P is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SUMITOMO P SP are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of SUMITOMO P i.e., SUMITOMO P and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between SUMITOMO P and Takeda Pharmaceutical

Assuming the 90 days trading horizon SUMITOMO P is expected to generate 1.04 times less return on investment than Takeda Pharmaceutical. In addition to that, SUMITOMO P is 1.82 times more volatile than Takeda Pharmaceutical. It trades about 0.09 of its total potential returns per unit of risk. Takeda Pharmaceutical is currently generating about 0.18 per unit of volatility. If you would invest  1,220  in Takeda Pharmaceutical on August 28, 2024 and sell it today you would earn a total of  40.00  from holding Takeda Pharmaceutical or generate 3.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.24%
ValuesDaily Returns

SUMITOMO P SP  vs.  Takeda Pharmaceutical

 Performance 
       Timeline  
SUMITOMO P SP 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SUMITOMO P SP has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable primary indicators, SUMITOMO P is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Takeda Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

SUMITOMO P and Takeda Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SUMITOMO P and Takeda Pharmaceutical

The main advantage of trading using opposite SUMITOMO P and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SUMITOMO P position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.
The idea behind SUMITOMO P SP and Takeda Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories